Rybelsus (semaglutide) Tablets 14 mg, 30 Tablets Per Bottle
Rybelsus is a prescription medicine used to treat the symptoms of Type 2 Diabetes Mellitus. RYBELSUS tablets, for oral use, contain semaglutide, a GLP-1 receptor agonist. The peptide backbone is produced by yeast fermentation.
Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists (glucagon-like peptide-1 receptor agonist).